MEA Contraceptives Market

MEA Contraceptives Market Size (2023 to 2028)

As per our report, the size of the Middle East & Africa Contraceptives Market was worth USD 2.60 billion in 2023 and estimated to reach USD 3.61 billion by the end of 2028, with a growing potential of 6.742%.

For the critical family procedures, adopting new permanent contraceptives is the primary driver in low-income countries.

An increasing need for population control and the growing incidence of STDs are two of the most impact rendering drivers of this industry. Moreover, the implementation of activities targeted at controlling unwanted pregnancy-associated healthcare spending and a growing level of awareness among the users should ensure positive market growth in the coming years.

The factors influencing the growth of the Middle East and Africa market are the growing development of capable female contraceptive devices and drugs, advancement in technologies, increasing number of initiatives from government and NGOs to promote contraceptives.

Side effects associated with the use of contraceptive devices and drugs and the rising prevalence of infertility are the restraints hampering the market's growth.

This research report on the MEA contraceptives market has been segmented & sub-segmented into the following categories:

By Drug Type: 

• Contraceptive Pills
• Topical Contraceptives
• Contraceptive Injectable
• Others (Contraceptive Gels, Jellies, and Creams)

By Medical Devices: 

• Male Contraceptive Devices (Condoms)
• Female Contraceptive Devices
  • Female Condoms
  • Intrauterine Devices
    • Hormonal IUD’s
    • Copper IUD’s
• Contraceptive Sponges
• Contraceptive Diaphragms
• Subdermal Contraceptive Implants
• Contraceptive Patches
• Non-Surgical Permanent Contraceptive Devices

By End User: 

• Hospitals
• Home Care
• Clinics
• Ambulatory Surgical Centres

By Country: 

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the usage of contraceptives is increasing in Saudi Arabia, and this country has high fertility and birth rates due to the growing population and large families. The perception of men using contraceptives is changing drastically, and they show acceptance towards use for birth spacing, which is estimated to boost the Saudi Arabia contraceptives market.

The African contraceptives market is estimated to register a healthy CAGR during the forecast period. The awareness regarding the usage of contraceptives in this region is growing significantly. Every year around 1.4 million unsafe abortion takes place among the girls aged 15-19 in Africa. State of Africa women report of 2018 says that the total fertility rate of the African continent is the highest in the world. The family planning organization noted that Africa recorded the most significant gains of modern contraceptive use in 2022.

KEY MARKET PLAYERS:

Companies playing a noteworthy role in the MEA contraceptives market profiled in this report are Bayer HealthCare AG, Teva Pharmaceutical Industries Limited, Medisafe Distribution Inc, Pace Pharmaceuticals Inc., Medicines360, Church & Dwight, Co., Inc., Actavis, Inc., CooperSurgical, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Mayer Laboratories, Inc., and Pfizer, Inc.